Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LASA SUPERGENERICS vs BERYL DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LASA SUPERGENERICS BERYL DRUGS LASA SUPERGENERICS/
BERYL DRUGS
 
P/E (TTM) x -5.5 49.4 - View Chart
P/BV x 1.3 1.9 69.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LASA SUPERGENERICS   BERYL DRUGS
EQUITY SHARE DATA
    LASA SUPERGENERICS
Mar-24
BERYL DRUGS
Mar-24
LASA SUPERGENERICS/
BERYL DRUGS
5-Yr Chart
Click to enlarge
High Rs4145 91.0%   
Low Rs1812 154.1%   
Sales per share (Unadj.) Rs20.852.7 39.5%  
Earnings per share (Unadj.) Rs-4.31.5 -286.0%  
Cash flow per share (Unadj.) Rs-2.23.9 -56.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs19.317.6 109.6%  
Shares outstanding (eoy) m50.105.07 988.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.40.5 263.2%   
Avg P/E ratio x-6.818.7 -36.3%  
P/CF ratio (eoy) x-13.37.3 -183.0%  
Price / Book Value ratio x1.51.6 94.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,475144 1,027.5%   
No. of employees `000NANA-   
Total wages/salary Rs m5417 312.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,043267 390.3%  
Other income Rs m15 21.2%   
Total revenues Rs m1,044272 383.8%   
Gross profit Rs m-6622 -297.4%  
Depreciation Rs m10712 888.7%   
Interest Rs m205 420.3%   
Profit before tax Rs m-19110 -1,892.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m262 1,086.3%   
Profit after tax Rs m-2178 -2,825.9%  
Gross profit margin %-6.38.2 -76.2%  
Effective tax rate %-13.723.9 -57.4%   
Net profit margin %-20.82.9 -724.3%  
BALANCE SHEET DATA
Current assets Rs m379105 359.4%   
Current liabilities Rs m48961 804.2%   
Net working cap to sales %-10.516.7 -63.0%  
Current ratio x0.81.7 44.7%  
Inventory Days Days214 18.3%  
Debtors Days Days1251,036 12.1%  
Net fixed assets Rs m1,13072 1,577.5%   
Share capital Rs m50151 983.5%   
"Free" reserves Rs m46638 1,216.1%   
Net worth Rs m96789 1,083.4%   
Long term debt Rs m024 0.0%   
Total assets Rs m1,509177 852.1%  
Interest coverage x-8.63.1 -274.7%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.71.5 45.8%   
Return on assets %-13.17.0 -186.5%  
Return on equity %-22.58.6 -261.0%  
Return on capital %-17.713.1 -135.2%  
Exports to sales %4.20-   
Imports to sales %0.20-   
Exports (fob) Rs m44NA-   
Imports (cif) Rs m2NA-   
Fx inflow Rs m440-   
Fx outflow Rs m20-   
Net fx Rs m430-   
CASH FLOW
From Operations Rs m218 260.9%  
From Investments Rs m-4-11 36.8%  
From Financial Activity Rs m-191 -1,875.7%  
Net Cashflow Rs m-2-2 120.9%  

Share Holding

Indian Promoters % 53.7 26.4 203.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 46.4 73.6 63.0%  
Shareholders   27,968 7,364 379.8%  
Pledged promoter(s) holding % 20.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LASA SUPERGENERICS With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on LASA SUPERGENERICS vs BERYL DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

LASA SUPERGENERICS vs BERYL DRUGS Share Price Performance

Period LASA SUPERGENERICS BERYL DRUGS S&P BSE HEALTHCARE
1-Day 1.93% 1.39% 1.23%
1-Month -5.19% -6.43% -0.24%
1-Year -5.95% 65.40% 43.62%
3-Year CAGR -24.56% 46.67% 20.35%
5-Year CAGR 6.11% 44.88% 26.24%

* Compound Annual Growth Rate

Here are more details on the LASA SUPERGENERICS share price and the BERYL DRUGS share price.

Moving on to shareholding structures...

The promoters of LASA SUPERGENERICS hold a 53.7% stake in the company. In case of BERYL DRUGS the stake stands at 26.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of LASA SUPERGENERICS and the shareholding pattern of BERYL DRUGS.

Finally, a word on dividends...

In the most recent financial year, LASA SUPERGENERICS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

BERYL DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of LASA SUPERGENERICS, and the dividend history of BERYL DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.